Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
β-Ketoacyl-acyl carrier protein (ACP) synthases are essential enzymes in the fatty acid biosynthesis pathway, catalyzing the condensation reactions that elongate fatty acid chains. They are found in both prokaryotes and eukaryotes, with isoforms like KASI, KASII, and KASIII having distinct roles. In bacteria, FabH (KASIII) is a validated target for novel antibacterial agents due to its role in initiating fatty acid synthesis.
Inhibition of fatty acid synthesis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on β-Ketoacyl-acyl Carrier Protein Synthase.